Allergan Management Discusses Q1 2012 Results - Earnings Call Transcript

Allergan (AGN)

Q1 2012 Earnings Call

May 02, 2012 11:00 am ET

Executives

James M. Hindman - Chief Financial Officer

David E.I. Pyott - Chairman, Chief Executive officer and President

Jeffrey L. Edwards - Chief Financial Officer and Executive Vice President of Finance & Business Development

Joann Bradley -

Analysts

Larry Biegelsen - Wells Fargo Securities, LLC, Research Division

Gregory Waterman - Goldman Sachs Group Inc., Research Division

Gary Nachman - Susquehanna Financial Group, LLLP, Research Division

Marc Goodman - UBS Investment Bank, Research Division

Douglas D. Tsao - Barclays Capital, Research Division

David G. Buck - The Buckingham Research Group Incorporated

Annabel Samimy - Stifel, Nicolaus & Co., Inc., Research Division

John T. Boris - Citigroup Inc, Research Division

Seamus Fernandez - Leerink Swann LLC, Research Division

Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division

Gregory B. Gilbert - BofA Merrill Lynch, Research Division

Shibani Malhotra - RBC Capital Markets, LLC, Research Division

David Risinger - Morgan Stanley, Research Division

Ken Cacciatore - Cowen and Company, LLC, Research Division

Catherine J. Arnold - Crédit Suisse AG, Research Division

Steve Willoughby - Cleveland Research Company

Frank H. Pinkerton - SunTrust Robinson Humphrey, Inc., Research Division

David Amsellem - Piper Jaffray Companies, Research Division

Presentation

Operator

Hello, and welcome to the Allergan First Quarter 2012 Earnings Call. [Operator Instructions] At the request of the company, today's conference is being recorded. If anyone has any objections, you may disconnect at this time. I would like to introduce today's conference host, Mr. Jim Hindman, Senior Vice President, Treasury, Risk and Investor Relations. Sir, you may begin.

James M. Hindman

Thank you, Terry. Good morning. With me for today's conference call is David Pyott, Chairman of the Board, President and Chief Executive Officer; Jeff Edwards, Executive Vice President, Finance and Business Development, Chief Financial Officer; Dr. Scott Whitcup, Executive Vice President, Research and Development, Chief Scientific Officer; and Jim Barlow, Senior Vice President and Corporate Controller.

If you liked this article you might like

Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways

Centene: Cramer's Top Takeaways

The Pitney Bowes Transformation: Cramer's Top Takeaways

Healthcare Trust of America, Marathon Petroleum: 'Mad Money' Lightning Round

How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)